{"nct_id":"NCT00708292","title":"A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma.","status":"COMPLETED","status_verified_date":"2015-06","start_date":"2008-07","start_date_type":null,"primary_completion_date":"2011-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}